Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.38 Billion CNY | 1.56% |
| 2022 | 14.44 Billion CNY | -20.11% |
| 2021 | 18.08 Billion CNY | 0.96% |
| 2020 | 17.9 Billion CNY | 21.91% |
| 2019 | 14.68 Billion CNY | 35.57% |
| 2018 | 10.83 Billion CNY | 31.5% |
| 2017 | 8.23 Billion CNY | 20.81% |
| 2016 | 6.82 Billion CNY | 23.47% |
| 2015 | 5.52 Billion CNY | 24.4% |
| 2014 | 4.44 Billion CNY | 22.78% |
| 2013 | 3.61 Billion CNY | 8.72% |
| 2012 | 3.32 Billion CNY | 21.73% |
| 2011 | 2.73 Billion CNY | 19.74% |
| 2010 | 2.28 Billion CNY | 24.95% |
| 2009 | 1.82 Billion CNY | 35.78% |
| 2008 | 1.34 Billion CNY | 8.87% |
| 2007 | 1.23 Billion CNY | 39.44% |
| 2006 | 886.04 Million CNY | 20.58% |
| 2005 | 734.84 Million CNY | 8.88% |
| 2004 | 674.88 Million CNY | 22.35% |
| 2003 | 551.59 Million CNY | 52.96% |
| 2002 | 360.61 Million CNY | 27.23% |
| 2001 | 283.44 Million CNY | 55.89% |
| 2000 | 181.82 Million CNY | 41.05% |
| 1999 | 128.9 Million CNY | 28.25% |
| 1998 | 100.51 Million CNY | 23.29% |
| 1997 | 81.52 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.56 Billion CNY | -9.57% |
| 2024 Q3 | 4.33 Billion CNY | -5.35% |
| 2024 Q2 | 4.5 Billion CNY | 26.53% |
| 2023 Q1 | 3.39 Billion CNY | -22.24% |
| 2023 Q4 | 3.94 Billion CNY | 7.29% |
| 2023 Q2 | 3.66 Billion CNY | 8.05% |
| 2023 Q3 | 3.67 Billion CNY | 0.26% |
| 2023 FY | 14.66 Billion CNY | 1.56% |
| 2022 Q2 | 3.05 Billion CNY | -8.29% |
| 2022 Q1 | 3.33 Billion CNY | -37.55% |
| 2022 Q4 | 4.36 Billion CNY | 18.18% |
| 2022 FY | 14.44 Billion CNY | -20.11% |
| 2022 Q3 | 3.68 Billion CNY | 20.62% |
| 2021 Q3 | 4.25 Billion CNY | 2.38% |
| 2021 Q2 | 4.15 Billion CNY | -3.84% |
| 2021 FY | 18.08 Billion CNY | 0.96% |
| 2021 Q1 | 4.32 Billion CNY | -23.47% |
| 2021 Q4 | 5.34 Billion CNY | 25.47% |
| 2020 FY | 17.9 Billion CNY | 21.91% |
| 2020 Q1 | 3.28 Billion CNY | -19.07% |
| 2020 Q2 | 3.72 Billion CNY | 13.63% |
| 2020 Q3 | 5.24 Billion CNY | 40.67% |
| 2020 Q4 | 5.64 Billion CNY | 7.69% |
| 2019 Q1 | 2.93 Billion CNY | -11.34% |
| 2019 FY | 14.68 Billion CNY | 35.57% |
| 2019 Q2 | 3.08 Billion CNY | 5.09% |
| 2019 Q3 | 4.61 Billion CNY | 49.42% |
| 2019 Q4 | 4.05 Billion CNY | -12.06% |
| 2018 Q2 | 2.31 Billion CNY | 2.42% |
| 2018 Q3 | 2.95 Billion CNY | 27.72% |
| 2018 FY | 10.83 Billion CNY | 31.5% |
| 2018 Q1 | 2.25 Billion CNY | 1.26% |
| 2018 Q4 | 3.31 Billion CNY | 12.16% |
| 2017 Q3 | 2.32 Billion CNY | 24.65% |
| 2017 Q1 | 1.81 Billion CNY | 0.58% |
| 2017 Q4 | 2.22 Billion CNY | -4.11% |
| 2017 Q2 | 1.86 Billion CNY | 2.52% |
| 2017 FY | 8.23 Billion CNY | 20.81% |
| 2016 Q4 | 1.8 Billion CNY | -5.05% |
| 2016 Q1 | 1.51 Billion CNY | 0.83% |
| 2016 Q3 | 1.9 Billion CNY | 19.4% |
| 2016 FY | 6.82 Billion CNY | 23.47% |
| 2016 Q2 | 1.59 Billion CNY | 5.64% |
| 2015 Q1 | 1.19 Billion CNY | -2.84% |
| 2015 Q4 | 1.49 Billion CNY | -4.38% |
| 2015 Q3 | 1.56 Billion CNY | 24.13% |
| 2015 Q2 | 1.26 Billion CNY | 5.43% |
| 2015 FY | 5.52 Billion CNY | 24.4% |
| 2014 Q1 | 940.25 Million CNY | -14.26% |
| 2014 FY | 4.44 Billion CNY | 22.78% |
| 2014 Q4 | 1.23 Billion CNY | -0.65% |
| 2014 Q3 | 1.24 Billion CNY | 20.65% |
| 2014 Q2 | 1.02 Billion CNY | 9.32% |
| 2013 Q3 | 938.65 Million CNY | 26.11% |
| 2013 Q2 | 744.31 Million CNY | -11.07% |
| 2013 FY | 3.61 Billion CNY | 8.72% |
| 2013 Q1 | 836.99 Million CNY | -3.5% |
| 2013 Q4 | 1.09 Billion CNY | 16.84% |
| 2012 Q4 | 867.37 Million CNY | -11.05% |
| 2012 Q1 | 738.26 Million CNY | -10.09% |
| 2012 Q2 | 745.84 Million CNY | 1.03% |
| 2012 Q3 | 975.13 Million CNY | 30.74% |
| 2012 FY | 3.32 Billion CNY | 21.73% |
| 2011 Q3 | 690.59 Million CNY | 12.51% |
| 2011 Q4 | 821.07 Million CNY | 18.89% |
| 2011 Q2 | 613.79 Million CNY | 1.06% |
| 2011 FY | 2.73 Billion CNY | 19.74% |
| 2011 Q1 | 607.32 Million CNY | -1.11% |
| 2010 Q4 | 614.14 Million CNY | 8.18% |
| 2010 Q1 | 553.64 Million CNY | 18.7% |
| 2010 Q2 | 546.67 Million CNY | -1.26% |
| 2010 Q3 | 567.72 Million CNY | 3.85% |
| 2010 FY | 2.28 Billion CNY | 24.95% |
| 2009 Q4 | 466.43 Million CNY | -11.42% |
| 2009 FY | 1.82 Billion CNY | 35.78% |
| 2009 Q2 | 444.72 Million CNY | 14.41% |
| 2009 Q1 | 388.71 Million CNY | 13.55% |
| 2009 Q3 | 526.56 Million CNY | 18.4% |
| 2008 Q4 | 342.34 Million CNY | -7.99% |
| 2008 Q3 | 372.05 Million CNY | 19.84% |
| 2008 Q2 | 310.45 Million CNY | -3.06% |
| 2008 Q1 | 320.25 Million CNY | -22.44% |
| 2008 FY | 1.34 Billion CNY | 8.87% |
| 2007 Q2 | 331.57 Million CNY | 42.67% |
| 2007 Q4 | 412.89 Million CNY | 59.65% |
| 2007 Q3 | 258.62 Million CNY | -22.0% |
| 2007 Q1 | 232.4 Million CNY | -6.2% |
| 2007 FY | 1.23 Billion CNY | 39.44% |
| 2006 Q2 | 209.61 Million CNY | 6.63% |
| 2006 Q1 | 196.58 Million CNY | 12.7% |
| 2006 Q4 | 247.75 Million CNY | 6.75% |
| 2006 FY | 886.04 Million CNY | 20.58% |
| 2006 Q3 | 232.08 Million CNY | 10.72% |
| 2005 Q1 | 193.23 Million CNY | 51.07% |
| 2005 Q2 | 179.37 Million CNY | -7.17% |
| 2005 Q3 | 187.78 Million CNY | 4.69% |
| 2005 Q4 | 174.43 Million CNY | -7.11% |
| 2005 FY | 734.84 Million CNY | 8.88% |
| 2004 Q2 | 188.66 Million CNY | 23.78% |
| 2004 FY | 674.88 Million CNY | 22.35% |
| 2004 Q4 | 127.91 Million CNY | -37.87% |
| 2004 Q1 | 152.42 Million CNY | -5.03% |
| 2004 Q3 | 205.88 Million CNY | 9.12% |
| 2003 Q1 | 112.05 Million CNY | -16.52% |
| 2003 Q3 | 142.89 Million CNY | 4.96% |
| 2003 FY | 551.59 Million CNY | 52.96% |
| 2003 Q4 | 160.49 Million CNY | 12.32% |
| 2003 Q2 | 136.14 Million CNY | 21.49% |
| 2002 Q4 | 134.23 Million CNY | 46.81% |
| 2002 Q2 | 71.74 Million CNY | 13.54% |
| 2002 Q1 | 63.19 Million CNY | 0.0% |
| 2002 FY | 360.61 Million CNY | 27.23% |
| 2002 Q3 | 91.43 Million CNY | 27.44% |
| 2001 FY | 283.44 Million CNY | 55.89% |
| 2000 FY | 181.82 Million CNY | 41.05% |
| 1999 FY | 128.9 Million CNY | 28.25% |
| 1998 FY | 100.51 Million CNY | 23.29% |
| 1997 FY | 81.52 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | -998.438% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | -356.81% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | -1224.498% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -2882.386% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -22340.367% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | -523.829% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -1657.472% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | -1220.565% |